Oncology nurses and APPs provide support and can help to facilitate conversations with patients and families during end-of-life care.

Restaging cancer can be an unfamiliar space, but with more experience, APPs can rely less on MDs for guidance in such cases.

Real-World Data Back First-Line Avelumab and Axitinib in Advanced RCC ...

Experts discuss the patient case of Janet, a 58-year-old with her 2 positive metastatic breast cancer, and after 14 months on ...

Alternating post-HCT care between specialized facilities and local cancer centers produced noninferior non-relapse mortality ...

In myeloma treatment, acute CRS is a common but treatable AE associated with CAR T-cell therapy and bispecific antibodies, ...

Patients with recurrent/metastatic HER2-positive breast cancer experienced durable response and manageable safety from ...

Patricia Jakel, MN, RN, AOCN, emphasized that the bond oncology nurses have with patients with cancer necessitates honest and ...

A recent study found that toxicity is routinely minimized in phase 3 oncology trials, especially those that are not industry ...

Although participants in the study had greater rates of nonadherence postintervention, those who reported nonadherence at ...

And again, it's very important that we educate the population. And when nurses are educated on the different subtypes of ...

Oncology nurses and APPs play a key role in educating patients on BREAKWATER study findings and their impact on BRAF-mutant ...